Navigation Links
John Theurer Cancer Center presents studies on promising therapies for aggressive blood cancers
Date:12/7/2010

HACKENSACK, N.J. (December 7, 2010 at 7:30am) The John Theurer Cancer Center at Hackensack University Medical Center announced today important research findings presented at the annual meeting of the American Society of Hematology (ASH) taking place December 4-7, 2010 in Orlando, Florida. The ASH meeting is the world's leading scientific gathering of hematologists and hematology researchers.

Research highlights from the 40 abstracts from the John Theurer Cancer Center include a comparison of treatment with stem cell transplantation versus continued combination drug therapy for early-stage myeloma; tests of a newly approved drug for patients unresponsive to a second-line therapy for an aggressive lymphoma; a phase 2 study of a promising acute myelogenous leukemia drug; a trial of a new proteasome inhibitor for myeloma patients whose disease had not responded to other therapies; a study comparing low and high-dose therapies in newly diagnosed myeloma; and a study of a new approach to increase the effectiveness of stem cell transplantation.

"This year, we showcased 12 oral sessions and 28 poster presentations at ASH, including multicenter, international trials in collaboration with leading cancer institutions, such as the National Cancer Institute, MD Anderson, Dana-Farber, Mayo Clinic, Cleveland Clinic and Memorial Sloan-Kettering," said Andrew L. Pecora, M.D., F.A.C.P., C.P.E., Chief Innovations Officer, Professor and Vice President of Cancer Services, John Theurer Cancer Center. "We are proud that our research improves outcomes for our patients and helps set new benchmarks for the cancer treatment community."

The studies presented by the John Theurer Cancer Center include research advancements in lymphoma, multiple myeloma, stem cell transplantation, and leukemia. Oral and poster presentation highlights being presented at ASH include:

A Randomized Clinical Trial of Lenalidomide Plus Dexamethasone Followed by Autolog
'/>"/>

Contact: Amy Leahing
amy.leahing@gmail.com
305-458-0599
John Theurer Cancer Center
Source:Eurekalert

Page: 1 2 3 4 5 6 7

Related medicine news :

1. The John Theurer Cancer Center to unveil 40 presentations at the 52nd ASH Annual Meeting
2. John Theurer Cancer Center to present innovative research at 2 surgical meetings
3. John Theurer Cancer Center first cancer center in N.J. to acquire new radiotherapy system
4. John Theurer Cancer Center and LLS host panel discussion with leading hematologists
5. The John Theurer Cancer Center recognizes medical physics team for safety track record
6. John Theurer Cancer Center experts present new cancer research at ASCO Annual Meeting
7. Leading physicians and researchers at the John Theurer Cancer Center present research at ASCO
8. John Theurer Cancer Center offers breakthrough radiation measurement technology
9. John Theurer Cancer Center hosts hematologic malignancies program for physicians and patients
10. Low-dose aspirin reduces death rates from range of cancers by between 20 and 30 percent
11. Daily Aspirin Linked to Steep Drop in Cancer Risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... its top dressmaking technologies, has been a leading dress supplier ... latest designs of wedding dresses and launching a site-wide promotion ... the fresh new products are designed for 2015, and they ... All the clothes from LunaDress follow up with the latest ...
(Date:1/22/2015)... VogueQueen is a seasoned and trusted leader who ... are thrilled to have it lead the wedding dress industry ... of prom dresses for the global market. , “The CEO ... and he focuses on continuing the goal of operational excellence ...
(Date:1/22/2015)... The federal court overseeing thousands of vaginal mesh ... District of West Virginia has upheld a $2 million verdict ... trial. In an Order dated January 21st, the Court denied ... C.R. Bard had not proven a miscarriage of justice. (Cisson ...
(Date:1/22/2015)... 20 years, Dr. David Cruz of Cruz Chiropractic Care ... about every type of injury that can result from car accidents ... years, the team at Doctors on Liens has been ... With the combined breadth of experience between the two, ...
(Date:1/22/2015)... has added many trendy Champagne wedding dresses to ... the past three years. Today, the business announces a special ... the sales manager of the company, this is on the ... point can be reflected on the discounted wedding dresses from ...
Breaking Medicine News(10 mins):Health News:LunaDress Shows The Latest Styles Of Wedding Dresses In 2015 2Health News:VogueQueen Unveils New Designs of Prom Dresses for 2015 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4Health News:Industry Leading Chiropractor in Oceanside Joins the Doctors on Liens Network 2Health News:Weddingshe Announces A Special Offer On Its Popular Glamorous Wedding Dresses 2
... Responding to,conditions created by Hurricane Ike in ... and Manufacturers of America (PhRMA) has moved,from "alert" ... activation - as,part of its effort to ensure ... storm. PhRMA is working closely with other members ...
... trend over the past four months within High-Tech Medical Device, specifically ... a “recruiters” market causing both parties to change their ways of ... ... Group, an executive search firm, today reports a hiring trend over ...
... Cancer patients,in Indonesia will gain access to ... Memorandum of Understanding (MOU) today between Varian,Medical ... first private cancer hospital.,Under the MOU, Siloam ... a,collaborative relationship to explore opportunities for developing,innovative ...
... ARAY ), a global leader in the field of ... chief financial,officer and senior vice president to pursue other ... March 2008, has been,appointed to serve as senior vice ... successor is found., "Robert McNamara has been a ...
... 11 ev3 Inc. (Nasdaq:,EVVV) today announced that Pat ... are scheduled to present at the 2008,UBS Life Sciences ... 2008 at the Grand Hyatt New York located at ... New York., To access the webcast, go to ...
... Blood,America, Inc. (OTC Bulletin Board: CBAI), the umbilical ... ) focused on,bringing the life saving potential of ... that CEO Matthew Schissler was interviewed,by Francis Gaskins, ... improving its market cap., The complete interview ...
Cached Medicine News:Health News:America's Pharmaceutical Research Companies Respond to Hurricane Ike's Imminent Landfall 2Health News:Lucas Group Reports Hiring Trend in High-Tech Medical Device 2Health News:Varian Medical Systems Signs Collaboration Agreement to Bring Advanced Radiotherapy Equipment to Indonesia 2Health News:Varian Medical Systems Signs Collaboration Agreement to Bring Advanced Radiotherapy Equipment to Indonesia 3Health News:Accuray Incorporated Announces Resignation of Chief Financial Officer 2Health News:Cord Blood America CEO Announces Aggressive Acquisition Strategy, Increased Investor Relations Efforts, New Stem Cell Storage Models 2
(Date:1/23/2015)...  Today the U.S. Food and Drug Administration (FDA) announced ... serogroup B meningococcal disease in individuals ages ... received FDA approval in October, represent a significant step ... "I have heard over and over from parents ...
(Date:1/23/2015)... new analysis of Centers for Medicare and Medicaid Services, ... 81 percent of seniors chose lower-cost preferred pharmacy plans ... pharmacies. The findings were released by Drug Channels ... foundation of Medicare Part D," said Pharmaceutical Care Management ...
(Date:1/23/2015)... /PRNewswire/-- Harwood Feffer LLP ( www.hfesq.com ) is investigating potential ... ("Advaxis" or the "Company") (NASDAQ: ADXS ), ... to shareholders. On January 21, 2015, an ... Advaxis had misrepresented the clinical data for its ADXS-HPV ...
Breaking Medicine Technology:The National Meningitis Association (NMA) Applauds FDA Approval of Second Vaccine To Protect Against Serogroup B Meningococcal Disease 2New Analysis: 81 Percent of Medicare Part D Seniors Choose "Preferred Pharmacy" Plans in 2015 2Harwood Feffer LLP Announces Investigation of Advaxis, Inc. 2
... Sigma-Aldrich Corporation (NASDAQ: SIAL ) will ... KeyBanc Capital Markets 2011 Basic Materials ... InterContinental, Boston, MA, presenting at 9:00 AM (Eastern). ... at the Grand Hyatt, New York, NY, presenting at ...
... SimonMed and Cox Business have partnered to make a ... patients in the Valley and across the state at ... is the first dedicated outpatient offering of breast tomosynthesis ... in Scottsdale. Sub-specialty trained radiologists at SimonMed ...
Cached Medicine Technology:Sigma-Aldrich Corporation to Present at Upcoming Investor Conferences 2SimonMed and Cox Business Bring Breast Tomosynthesis to Arizona 2
Medium Surgical Clips. 6 clips per cartridge. Box of 30 cartridges with a total of 180 titanium clips per box. For secure vasal and other occlusion....
Sterile Disposable Thermal Cautery Tips for Vasectomy. Individually peel-pouched with dual plastic sheaths to cover non-sterile handle. Box of 10 tips....
Li Brand™ Surgical Hemostat. ("dissecting clamp") For NSV and other procedures....
Platinum General Purpose Cautery Electrodes , ,A - Loop Tip, ,Fully autoclavable. Tips typically last for 50 to 100 or more procedures, depending on burn time....
Medicine Products: